Market Overview
The global Protein Biological Reagents market was valued at USD 6.12 billion in 2024.
The market is projected to grow from USD 6.62 billion in 2025 to USD 10.51 billion by 2031, exhibiting a CAGR of 8.2% during the forecast period.
Protein biological reagents are essential consumables used in life science research and development, particularly in experiments involving protein macromolecules.
These reagents include antibodies, recombinant proteins, protein chips, and other specialized reagents that enable researchers to study protein structure, function, and interactions.
USD 10.51 billion by 2031 USD 6.12 billion in 2024
of 8.2%
Monoclonal Antibodies Polyclonal Antibodies
Monoclonal Antibodies continue to dominate due to their superior specificity and consistency in research applications, while demand for Polyclonal
Antibodies remains steady in applications requiring broader epitope coverage.
By Application
Drug Discovery & Development
Clinical Diagnostics
Academic & Government Research
Biopharmaceutical Production
Drug Discovery & Development represents the largest revenue segment as pharmaceutical companies heavily invest in precision medicine and personalized treatment development, driving consistent demand for high-quality protein reagents with stringent quality requirements.
Our Key Players
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Abcam plc (UK)
Bio-Rad Laboratories, Inc. (US)
Sartorius AG (Germany)
Agilent Technologies, Inc. (US)
Qiagen N.V. (Netherlands)
https://www.24lifesciences.com
